Curebound Connects

San Diego BioMed is excited to share its new partnership with Curebound, a San Diego philanthropic organization that is dedicated to raising and strategically investing funds in translational cancer research.

Recently, San Diego BioMed principal investigators joined Curebound and other partners for the event, Curebound Connects, where CEO Robin Toft, Chief Science Advisor, Ezra Cohen, MD and Scientific Advisory leaders introduced their strategic plan and vision for the future of cancer research.

Cancer is a complex, multifaceted disease that San Diego BioMed scientists are attacking from multiple fronts. Through this partnership, with aligned goals and complementary strengths, we will enhance innovation, bridge the gap between discovery and treatment, and accelerate the impact of cancer research on patient health and quality of life.

Thank you, Curebound, we are excited for the journey ahead!

Learn more about Curebound by clicking here!